A City In The Sea, Built Inside Wind Turbines


As the wind sector continues to grow, the workers who inspect offshore turbines will need practical places to live.

The Wind Turbine Loft is a new kind of creative housing for this class of workers.

One day, wind turbines may not only power residential units. They’ll be residential units.

That’s the thinking behind the Wind Turbine Loft, an architectural project that seeks to create housing for the hordes of technicians who will some day need to monitor the well-being of offshore wind farms. This group is poised to become an increasingly important component of a post-oil energy sector.

Inspired by the Edgar Allan Poe poem “The City in the Sea,” mock-ups for the units show simple but spacious living accommodations complete with modern furniture, plants, natural lighting, and–of course–dazzling views of the heaving ocean and twirling turbines.

The project’s founders, Greta Dimitrova and Kiril Mandov of the Bulgarian architecture studio Morphocode, say that the current process of inspecting off-shore turbines for structural integrity and performance standards can mean turning off the turbines for several days at great expense. “The extreme height and the possibly short weather windows during which the whole inspection must be carried out make the task not only expensive but also risky for the safety of the support technicians,” they explain over email.

Read more . . .


The Latest on: Wind Turbines

via Google News and Bing News

Physician reveals drug breakthrough for asthma patients

Startling results of a research trial in Bradford into the effectiveness of a drug to treat severe allergic asthma have been presented to the European Respiratory Society congress in Vienna.

Bradford Teaching Hospitals NHS Foundation Trust was one of several centres taking part in a Novartis Pharmaceuticals trial of a drug called omalizumab, a humanised monoclonal antibody that blocks the action of immunoglobulin E, an antibody involved in the underlying mechanism of allergic asthma, a chronic condition which affects an estimated 14,315 people in the UK.

Asthma causes an average of three deaths in the UK every day, 90 per cent of which are preventable with the right management.

Dr Dinesh Saralaya, a consultant respiratory physician at Bradford Teaching Hospitals NHS Foundation Trust, said the findings showed long-term treatment with omalizumab significantly improved a range of outcomes for people with severe persistent allergic asthma.

People using the drug for two years or more saw a 100 per reduction in GP visits, admissions to intensive care units were reduced by up to 95.2 per cent, hospital bed days were reduced by up to 97.8 per cent, accident and emergency visits were reduced by up to 82.1 per cent and the mean maintenance dose of oral corticosteroids was reduced by up to 68.3 per cent.

Read more . . .

via Telegraph & Argus

The Latest Streaming News: Breakthrough for asthma updated minute-by-minute

Bookmark this page and come back often

Latest NEWS


Latest VIDEO


The Latest from the BLOGOSPHERE